{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-032827","form_type":"8-K/A","ticker":"PROK","cik":"0001850270","company_name":"PROKIDNEY CORP.","filed_at":"2024-03-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:26.008619+00:00","generated_at":"2026-06-04T15:45:17.824410+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"ProKidney Corp. finalizes separation agreement with former COO Deepak Jain including $495K severance","bullets":["Severance pay of $495,000 (12 months base salary) plus eligibility for 2023 bonus up to 45% of base salary.","Company will pay 100% of COBRA/Medicare premiums through November 30, 2024.","Legal fee reimbursement up to $20,000 for negotiation of separation agreement.","Vested stock options exercisable for 90 days after effective date; all unvested awards forfeited.","Vested Class B shares: 783,969 convertible to Class A; 406,087 remain under lockup until July 11, 2026 or regulatory event."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-032827","json":"https://secwatch.observer/filing/0000950170-24-032827.json","markdown":"https://secwatch.observer/filing/0000950170-24-032827.md","text":"https://secwatch.observer/filing/0000950170-24-032827.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1850270/000095017024032827/0000950170-24-032827-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1850270/000095017024032827/prok-20231128.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T15:45:17.824410+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"39340ab7a4","claim":"Deepak Jain resigned as Chief Operating Officer at PROKIDNEY CORP..","evidence_excerpt":"On March 13, 2024 (the “Effective Date”), the Company entered into a Separation Agreement (the “Separation Agreement”) with Dr. Jain.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1850270/000095017024032827/0000950170-24-032827-index.htm","confidence":0.85,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Operating Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}